Post by Lonza

Innovation in ADCs and small molecules is moving fast—and getting more complex. From advanced linker technologies to integrated development strategies and strategic partnerships, the way we bring therapies to market is evolving fast. Our latest Advanced Synthesis in Focus newsletter brings it all together: 🔹 Expert insights on why linker innovation is critical 🔹 Perspectives on managing developability and manufacturing risks 🔹 A closer look at navigating complexity in small molecule development 🔹 Upcoming webinars to help you stay ahead For teams looking to accelerate advanced therapies with confidence—this is worth a read. 👉 Explore the full newsletter